2 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Pharmasyntez: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Dose Ranging Study of Seroguard Seroguard, Placebo - Adhesion | Phase 2 | Completed | Pharmasyntez | 114 | 2017-05-04 | 2019-06-19 |
| Safety and Tolerability of Seroguard Use Seroguard, Placebos - Adhesion | Phase 1 | Completed | Pharmasyntez | 50 | 2015-05-19 | 2019-05-03 |
| Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA Sodium cridanimod - Recurrent or Persistent Endometrial Carcinoma | Phase 2 | Unknown | Kevelt AS | 8 | 2014-09-01 | 2017-01-24 |
Tissue Adhesions (2) · Endometrial Neoplasms (1) · Recurrence (1)
10-carboxymethyl-9-acridanone (1)
Belarus (1) · Czechia (1) · Russia (1) · Slovakia (1) · Ukraine (1) · United States (1)
Laura L. Douglass (1) · Mikhail Shurygin, PhD (1) · Mikhail Shurygin, PhD,D.M.Sc. (1)